Comprehensive clinical commissioning and validation of the RayStation treatment planning system for proton therapy with active scanning and passive treatment techniques

•RayStation has been commissioned for treatment planning in proton therapy.•By and large, the dose distribution in RayStation agrees with the dose in XiO.•It has an accurate modelling of the lateral dose fall-off of passive fields.•The computation of perturbed doses allows assessing the CTV coverage...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Physica medica 2017-11, Vol.43, p.15-24
Hauptverfasser: Bäumer, C., Geismar, D., Koska, B., Kramer, P.H., Lambert, J., Lemke, M., Plaude, S., Pschichholz, L., Qamhiyeh, S., Schiemann, A., Timmermann, B., Vermeren, X.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•RayStation has been commissioned for treatment planning in proton therapy.•By and large, the dose distribution in RayStation agrees with the dose in XiO.•It has an accurate modelling of the lateral dose fall-off of passive fields.•The computation of perturbed doses allows assessing the CTV coverage. To commission the treatment planning system (TPS) RayStation for proton therapy including beam models for spot scanning and for uniform scanning. Tests consist of procedures from ESTRO booklet number 7, the German DIN for constancy checks of TPSs, and extra tests checking the dose perturbation function. The dose distributions within patients were verified in silico by a comparison of 65 clinical treatment plans with the TPS XiO. Dose-volume parameters, dose differences, and three-dimensional gamma-indices serve as measures of similarity. The monthly constancy checks of Raystation have been automatized with a script. The basic functionality of the software complies with ESTRO booklet number 7. For a few features minor enhancements are suggested. The dose distribution in RayStation agrees with the calculation in XiO. This is supported by a gamma-index (3mm/3%) pass rate of >98.9% (median over 59 plans) for the volume within the 20% isodose line and a difference of
ISSN:1120-1797
1724-191X
DOI:10.1016/j.ejmp.2017.09.136